Table 5 |
||||
|
Generalised estimating equations testing effect of CRP and ESR on SEVR, MBP and augmentation index |
||||
|
Outcome |
Effect of CRPa |
Effect of ESRa |
||
|
Coefficient (95% CI) |
P value |
Coefficient (95% CI) |
P value |
|
|
|
||||
|
SEVRa |
-0.031 (-0.059 to -0.004) |
0.02 |
-0.028 (-0.079 to 0.023) |
0.28 |
|
MBPa |
0.009 (-0.009 to 0.026)b |
0.34b |
-0.009 (-0.033 to 0.015)b |
0.48b |
|
AIx |
5.434 (1.769 to 7.299) |
0.001 |
-1.887 (-4.877 to 1.104) |
0.22 |
|
|
||||
|
AIx, augmentation index; CI, confidence interval; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; MBP, mean blood pressure; SEVR, subendocardial viability ratio. From a generalised estimating equation, with unstructured correlation structure, unless stated otherwise. aLog10-transformed prior to analysis. bExchangeable correlation structure used. |
||||
|
Sandoo et al. Arthritis Research & Therapy 2012 14:R258 doi:10.1186/ar4103 |
||||